Clinical Trial Update: Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial compares relugolix with leuprolide to assess effects on cardiac function in men with prostate cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuprolide (Leuprolide acetate)
• Relugolix (Relugolix)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8 | Phase 2 | Status: RECRUITING